Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ironwood Pharmaceuticals, Inc. (IRWD)
USD4.05
-0.17 (-3.92%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
100 Summer Street 2110
Boston, MA, US
Boston, MA, US
CEO
Thomas A. McCourt
Website
ironwoodpharma.com
IPO
2010-02-03
CIK 1446847 ISIN US46333X1081
Description
Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.
News Sentiment (7d)
Based on only 1 article — low confidence
- 4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.05
-0.17 (-3.92%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.21
Float Shares
156.39M
Free Float %
95.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.18% | -10.90% | +14.88% | -9.54% | +34.08% | +23.74% | +468.27% | -58.84% | -62.63% | -59.55% | -64.21% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (30 ratings, all time)
Hold
Price Targets & DCF
Current price
4.05
Low
3.70
-8.5%
Consensus
4.80
+18.7%
Median
5.00
+23.6%
High
5.70
+40.9%
DCF (Unlevered)
6.35
+57.0%
DCF (Levered)
11.97
+195.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
3.70
-8.5%
|
| Last Year | 4 |
4.55
+12.5%
|
| All Time | 11 |
8.29
+104.9%
|
Quality scores
Altman Z-Score
-1.99
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-15.7% Q1'26: +158.9% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+2,627.3% ★ Q1'26: +204.3% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+22.1% ★ Q1'26: +4.8% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+34.7% ★ Q1'26: +68.1% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+51.2% ★ Q1'26: +181.6% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+11.0% Q1'26: +3.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×5.71× Q1'26: 2.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 1 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
65.87M
est: 83.23M (-20.9%)
|
150.25M
est: 81.70M (+83.9%)
|
22.88M
est: 25.44M (-10.1%)
|
76.44M
est: 69.74M (+9.6%)
|
149.56M
est: 138.84M (+7.7%)
|
273.96M
est: 262.74M (+4.3%)
|
298.28M
est: 289.90M (+2.9%)
|
346.64M
est: 308.65M (+12.3%)
|
428.41M
est: 415.96M (+3.0%)
|
389.52M
est: 383.96M (+1.4%)
|
413.75M
est: 407.40M (+1.6%)
|
410.60M
est: 411.69M (-0.3%)
|
442.74M
est: 413.55M (+7.1%)
|
351.41M
est: 354.62M (-0.9%)
|
296.15M
est: 299.09M (-1.0%)
|
459.38M
454.04M – 463.60M
+53.6% YoY
|
478.30M
472.75M – 482.70M
+4.1% YoY
|
488.93M
488.77M – 489.10M
+2.2% YoY
|
263.50M
260.44M – 265.92M
-46.1% YoY
|
168.50M
166.54M – 170.05M
-36.1% YoY
|
| EBITDA |
-54.79M
est: -54.43M (-0.7%)
|
-61.24M
est: -35.87M (-70.7%)
|
-240.08M
est: -236.85M (-1.4%)
|
-156.12M
est: -143.05M (-9.1%)
|
-99.94M
est: -74.42M (-34.3%)
|
-31.30M
est: -33.50M (+6.6%)
|
-33.12M
est: -48.43M (+31.6%)
|
-144.45M
est: -193.48M (+25.3%)
|
128.55M
est: 162.02M (-20.7%)
|
141.90M
est: 102.46M (+38.5%)
|
233.74M
est: 202.87M (+15.2%)
|
261.44M
est: 281.61M (-7.2%)
|
197.41M
est: 188.50M (+4.7%)
|
97.73M
est: 161.64M (-39.5%)
|
104.65M
est: 136.33M (-23.2%)
|
209.38M
206.95M – 211.31M
+53.6% YoY
|
218.01M
215.48M – 220.01M
+4.1% YoY
|
222.86M
222.78M – 222.93M
+2.2% YoY
|
120.10M
118.71M – 121.21M
-46.1% YoY
|
76.80M
75.91M – 77.51M
-36.1% YoY
|
| EBIT |
-64.79M
est: -66.52M (+2.6%)
|
-72.57M
est: -46.95M (-54.5%)
|
-251.81M
est: -249.20M (-1.0%)
|
-168.45M
est: -155.11M (-8.6%)
|
-111.57M
est: -77.71M (-43.6%)
|
-42.56M
est: -55.39M (+23.2%)
|
-18.55M
est: -58.54M (+68.3%)
|
-156.42M
est: -190.79M (+18.0%)
|
122.97M
est: 197.40M (-37.7%)
|
138.34M
est: 104.04M (+33.0%)
|
232.22M
est: 201.13M (+15.5%)
|
260.02M
est: 278.67M (-6.7%)
|
195.84M
est: 186.61M (+4.9%)
|
95.72M
est: 160.02M (-40.2%)
|
102.77M
est: 134.96M (-23.9%)
|
207.29M
204.89M – 209.20M
+53.6% YoY
|
215.83M
213.33M – 217.82M
+4.1% YoY
|
220.63M
220.56M – 220.71M
+2.2% YoY
|
118.90M
117.52M – 120.00M
-46.1% YoY
|
76.04M
75.15M – 76.73M
-36.1% YoY
|
| Net Income |
-64.85M
est: -65.22M (+0.6%)
|
-72.62M
est: -46.82M (-55.1%)
|
-272.81M
est: -270.72M (-0.8%)
|
-189.62M
est: -173.84M (-9.1%)
|
-142.67M
est: -114.44M (-24.7%)
|
-81.71M
est: -92.05M (+11.2%)
|
-116.94M
est: -99.96M (-17.0%)
|
-282.37M
est: -243.70M (-15.9%)
|
21.51M
est: 81.21M (-73.5%)
|
106.18M
est: 74.32M (+42.9%)
|
528.45M
est: 357.75M (+47.7%)
|
175.07M
est: 203.32M (-13.9%)
|
-1.00B
est: -1.20B (+16.3%)
|
880.0K
est: 17.26M (-94.9%)
|
24.02M
est: 20.71M (+16.0%)
|
242.56M
239.28M – 245.85M
+1,071.4% YoY
|
249.07M
245.70M – 252.44M
+2.7% YoY
|
283.09M
279.25M – 286.92M
+13.7% YoY
|
99.55M
98.05M – 100.74M
-64.8% YoY
|
56.88M
56.03M – 57.56M
-42.9% YoY
|
| SGA |
45.92M
est: 50.28M (-8.7%)
|
92.54M
est: 10.49M (+782.3%)
|
123.23M
est: 3.27M (+3,673.2%)
|
118.33M
est: 8.95M (+1,221.5%)
|
125.25M
est: 112.94M (+10.9%)
|
173.28M
est: 209.40M (-17.2%)
|
233.12M
est: 240.04M (-2.9%)
|
241.29M
est: 247.90M (-2.7%)
|
—
est: 345.34M (-100.0%)
|
140.00M
est: 114.74M (+22.0%)
|
—
est: 97.57M (-100.0%)
|
115.99M
est: 137.75M (-15.8%)
|
—
est: 46.34M (-100.0%)
|
—
est: 39.74M (-100.0%)
|
82.26M
est: 33.51M (+145.4%)
|
51.47M
50.88M – 51.95M
+53.6% YoY
|
53.59M
52.97M – 54.09M
+4.1% YoY
|
54.79M
54.77M – 54.80M
+2.2% YoY
|
29.53M
29.18M – 29.80M
-46.1% YoY
|
18.88M
18.66M – 19.05M
-36.1% YoY
|
| EPS |
-0.65
est: -0.70 (+7.1%)
|
-0.68
est: -0.78 (+12.8%)
|
-2.35
est: -2.45 (+4.1%)
|
-1.39
est: -1.25 (-11.2%)
|
-1.00
est: -0.88 (-13.7%)
|
-0.56
est: -0.55 (-1.9%)
|
-0.79
est: -0.89 (+11.5%)
|
-1.85
est: -1.36 (-35.9%)
|
-0.10
est: 0.13 (-174.6%)
|
0.67
est: 0.68 (-1.1%)
|
3.26
est: 3.26 (+0.2%)
|
1.13
est: 0.97 (+16.3%)
|
-6.45
est: -6.73 (+4.2%)
|
0.01
est: 0.08 (-92.9%)
|
0.15
est: 0.12 (+28.6%)
|
1.37
1.35 – 1.38
+1,071.4% YoY
|
1.40
1.38 – 1.42
+2.7% YoY
|
1.60
1.57 – 1.61
+13.7% YoY
|
0.56
0.55 – 0.57
-64.9% YoY
|
0.32
0.32 – 0.32
-42.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 4/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | B- | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B- | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B- | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B- | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B- | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B- | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | B- | 3/5 | 5/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
114.54M
OE per share TTM
0.64
Owner's Yield
16.80%
Maintenance CapEx ratio
3.88%
Maint CapEx / Avg PPE
5.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
52
Total invested
12.54M
Insider transactions (90d)
0
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ironwood Pharmaceuticals, Inc. | 61.30M | 97.60% | 61.30M | — | 61.30M | — | CO | — | 2023-07-07 | ↗ |
| 2 | (1) BlackRock, Inc. | 26.90M | 17.50% | 26.38M | — | 26.90M | — | HC | Delaware | 2022-07-08 | ↗ |
| 3 | Wellington Group Holdings LLP | 21.65M | 13.53% | — | 20.06M | — | — | HC | Massachusetts | 2021-02-04 | ↗ |
| 4 | Wellington Investment Advisors Holdings LLP | 21.65M | 13.53% | — | 20.06M | — | — | HC | Massachusetts | 2021-02-04 | ↗ |
| 5 | Wellington Management Company LLP | 19.51M | 12.19% | — | 19.48M | — | — | IA | Massachusetts | 2021-02-04 | ↗ |
| 6 | Wellington Management Group LLP | 17.34M | 10.59% | — | 15.83M | — | 17.34M | HC | Massachusetts | 2022-02-04 | ↗ |
| 7 | Brown Capital Management, LLC | 16.26M | 9.93% | 11.45M | — | 16.26M | — | IA | State of Maryland | 2022-02-14 | ↗ |
| 8 | Alexander J. Denner, Ph.D. | 14.93M | 9.30% | 37.8K | 14.89M | 37.8K | 10.00 | IN | United States | 2021-03-01 | ↗ |
| 9 | Sarissa Capital Management LP | 14.89M | 9.30% | — | 14.89M | — | 10.00 | PN | Delaware | 2021-03-01 | ↗ |
| 10 | The Vanguard Group - 23-1945930 | 13.49M | 8.24% | — | 291.7K | — | — | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 11 | The Brown Capital Management Small Company Fund | 9.98M | 6.10% | 9.98M | — | 9.98M | — | IV | State of Maryland | 2022-02-14 | ↗ |
| 12 | STATE STREET CORPORATION | 9.92M | 6.20% | — | 9.42M | — | — | HC | MA | 2024-10-16 | ↗ |
| 13 | PERSON Janus Henderson Group plc EIN #00-0000000 | 8.29M | 11.00% | — | 8.29M | — | 8.29M | — | Jersey Channel Islands | 2020-02-14 | ↗ |
| 14 | Armistice Capital, LLC | 8.20M | 5.13% | — | 8.20M | — | — | IA, OO | Delaware | 2024-11-14 | ↗ |
| 15 | Steven Boyd | 8.20M | 5.13% | — | 8.20M | — | — | HC, IN | United States of America | 2024-11-14 | ↗ |
| 16 | Westfield Capital Management Company, LP | 8.15M | 4.98% | 7.39M | — | 8.15M | — | IA | Massachusetts | 2022-02-01 | ↗ |
| 17 | 23-2772200 | 7.93M | 5.17% | 5.27M | — | 7.93M | — | IA | State of Delaware | 2023-02-10 | ↗ |
| 18 | Sarissa Capital Offshore Master Fund LP | 5.68M | 3.59% | 5.68M | — | 5.68M | 10.00 | PN | Cayman Islands | 2020-02-26 | ↗ |
| 19 | Sarissa Capital Athena Fund Ltd | 2.04M | 1.29% | 2.04M | — | 2.04M | 10.00 | OO | Cayman Islands | 2020-02-26 | ↗ |
| 20 | Sarissa Capital Catapult Fund LLC | 1.95M | 1.23% | 1.95M | — | 1.95M | 10.00 | OO | Delaware | 2020-02-26 | ↗ |
| 21 | Sarissa Capital Hawkeye Fund LP | 1.47M | 0.93% | 1.47M | — | 1.47M | 10.00 | PN | Delaware | 2020-02-26 | ↗ |
| 22 | 98-0186363 | 98.00 | 1.21% | — | — | — | — | HC | Switzerland | 2021-02-12 | ↗ |
| 23 | EIN #00-0000000 | — | 0.00% | — | — | — | — | IA, HC | Jersey Channel Islands | 2021-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
52
-152 vs prev Q
New positions
11
Closed positions
157
Increased
29
Reduced
9
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 16.03M -125.0K (-0.8%) | 54.00M +32.8M (+155.3%) | 9.88% -0.107 pp | 0.64% +0.329 pp | USD5.37 -37.2% | 10 qtrs — |
| 2 | VANGUARD GROUP INC | 15.96M -113.8K (-0.7%) | 53.78M +32.7M (+155.4%) | 9.84% -0.100 pp | 0.00% +0.001 pp | USD11.00 -69.4% | 64 qtrs — |
| 3 | SARISSA CAPITAL MANAGEMENT LP | 15.92M +— (+0.0%) | 53.65M +32.8M (+157.3%) | 9.81% -0.030 pp | 24.07% +12.507 pp | USD11.97 -71.8% | 33 qtrs — |
| 4 | BLACKROCK, INC. | 12.78M +722.2K (+6.0%) | 43.08M +27.3M (+172.7%) | 7.88% +0.423 pp | 0.00% +0.001 pp | USD4.03 -16.4% | 6 qtrs — |
| 5 | BANK OF AMERICA CORP /DE/ | 11.52M -173.9K (-1.5%) | 38.83M +23.5M (+153.4%) | 7.10% -0.129 pp | 0.00% +0.002 pp | USD1.62 +108.0% | 52 qtrs — |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 8.20M -147.2K (-1.8%) | 27.65M +16.7M (+152.7%) | 5.06% -0.106 pp | 0.04% +0.029 pp | USD9.25 -63.6% | 28 qtrs — |
| 7 | ACADIAN ASSET MANAGEMENT LLC | 6.46M -44.7K (-0.7%) | 21.75M +13.2M (+155.7%) | 3.98% -0.040 pp | 0.04% +0.021 pp | USD1.44 +134.0% | 6 qtrs — |
| 8 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.98M +58.6K (+1.2%) | 16.77M +10.3M (+160.3%) | 3.07% +0.027 pp | 0.00% +0.002 pp | USD4.71 -28.5% | 61 qtrs — |
| 9 | AQR CAPITAL MANAGEMENT LLC | 4.72M -655.0K (-12.2%) | 15.92M +8.9M (+125.9%) | 2.91% -0.414 pp | 0.01% +0.004 pp | USD1.46 +130.8% | 28 qtrs — |
| 10 | MARSHALL WACE, LLP | 4.42M +1.3M (+40.7%) | 14.91M +10.8M (+262.0%) | 2.73% +0.783 pp | 0.01% +0.009 pp | USD1.56 +116.0% | 4 qtrs — |
| 11 | STATE STREET CORP | 4.41M +1.3M (+39.8%) | 14.87M +10.7M (+259.5%) | 2.72% +0.768 pp | 0.00% +0.000 pp | USD8.66 -61.1% | 51 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 3.62M +8.5K (+0.2%) | 12.21M +7.5M (+157.9%) | 2.23% -0.002 pp | 0.00% +0.001 pp | USD11.26 -70.1% | 64 qtrs — |
| 13 | FEDERATED HERMES, INC. | 3.32M +1.2M (+53.8%) | 11.18M +8.4M (+295.7%) | 2.05% +0.712 pp | 0.02% +0.014 pp | USD2.27 +48.5% | 5 qtrs — |
| 14 | TWO SIGMA ADVISERS, LP | 3.14M -176.4K (-5.3%) | 10.58M +6.2M (+143.6%) | 1.94% -0.115 pp | 0.02% +0.012 pp | USD4.79 -29.6% | 30 qtrs — |
| 15 | TWO SIGMA INVESTMENTS, LP | 2.85M +318.7K (+12.6%) | 9.62M +6.3M (+189.6%) | 1.76% +0.192 pp | 0.01% +0.009 pp | USD3.72 -9.4% | 30 qtrs — |
| 16 | JANE STREET GROUP, LLC | 2.82M +498.5K (+21.5%) | 9.50M +6.5M (+212.5%) | 1.74% +0.303 pp | 0.00% +0.001 pp | USD2.08 +62.0% | 23 qtrs — |
| 17 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.76M +839.1K (+43.7%) | 9.30M +6.8M (+269.7%) | 1.70% +0.514 pp | 0.04% +0.026 pp | USD6.32 -46.7% | 10 qtrs — |
| 18 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 1.99M -170.9K (-7.9%) | 6.71M +3.9M (+136.9%) | 1.23% -0.109 pp | 0.02% +0.009 pp | USD1.72 +95.9% | 13 qtrs — |
| 19 | QUBE RESEARCH & TECHNOLOGIES LTD | 1.68M -1.1M (-40.1%) | 5.67M +2.0M (+54.1%) | 1.04% -0.699 pp | 0.01% +0.002 pp | USD1.66 +103.0% | 6 qtrs — |
| 20 | GOLDMAN SACHS GROUP INC | 1.28M +190.9K (+17.6%) | 4.30M +2.9M (+202.6%) | 0.79% +0.116 pp | 0.00% +0.000 pp | USD6.12 -44.9% | 63 qtrs — |
| 21 | NORTHERN TRUST CORP | 1.23M -107.2K (-8.0%) | 4.16M +2.4M (+136.7%) | 0.76% -0.069 pp | 0.00% +0.000 pp | USD10.86 -69.0% | 51 qtrs — |
| 22 | HILLSDALE INVESTMENT MANAGEMENT INC. | 1.16M +1.2M (+100.0%) | 3.90M +3.9M (+100.0%) | 0.71% +0.713 pp | 0.11% +0.108 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 23 | DEUTSCHE BANK AG\ | 1.11M -417.3K (-27.3%) | 3.74M +1.7M (+87.0%) | 0.68% -0.260 pp | 0.00% +0.001 pp | USD7.75 -56.5% | 50 qtrs — |
| 24 | LAZARD ASSET MANAGEMENT LLC | 1.00M +1.0M (+100.0%) | 3.37M +3.4M (+100.0%) | 0.62% +0.617 pp | 0.01% +0.006 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 25 | RAYMOND JAMES FINANCIAL INC | 869.8K +854.8K (+5,681.1%) | 2.93M +2.9M (+14,772.2%) | 0.54% +0.527 pp | 0.00% +0.001 pp | USD3.39 -0.6% | 5 qtrs — |
| 26 | MORGAN STANLEY | 739.7K +262.6K (+55.0%) | 2.49M +1.9M (+298.8%) | 0.46% +0.161 pp | 0.00% +0.000 pp | USD6.97 -51.6% | 51 qtrs — |
| 27 | FMR LLC | 686.7K +126.8K (+22.6%) | 2.31M +1.6M (+215.5%) | 0.42% +0.077 pp | 0.00% +0.000 pp | USD4.12 -18.2% | 64 qtrs — |
| 28 | DIADEMA PARTNERS LP | 683.6K +683.6K (+100.0%) | 2.30M +2.3M (+100.0%) | 0.42% +0.421 pp | 0.40% +0.397 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 29 | SEI INVESTMENTS CO | 673.9K -9.7K (-1.4%) | 2.27M +1.4M (+153.6%) | 0.42% -0.007 pp | 0.00% +0.001 pp | USD1.47 +129.3% | 6 qtrs — |
| 30 | EXOME ASSET MANAGEMENT LLC | 648.5K +648.5K (+100.0%) | 2.19M +2.2M (+100.0%) | 0.40% +0.400 pp | 1.05% +1.045 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 31 | AMUNDI | 642.8K +642.8K (+100.0%) | 2.17M +2.2M (+100.0%) | 0.40% +0.396 pp | 0.00% +0.001 pp | USD3.37 +0.0% | 14 qtrs — |
| 32 | IEQ CAPITAL, LLC | 633.3K -28.4K (-4.3%) | 2.13M +1.3M (+146.2%) | 0.39% -0.019 pp | 0.01% +0.004 pp | USD1.08 +212.0% | 4 qtrs — |
| 33 | GSA CAPITAL PARTNERS LLP | 571.6K +262.1K (+84.7%) | 1.93M +1.5M (+375.6%) | 0.35% +0.161 pp | 0.17% +0.132 pp | USD2.27 +48.5% | 8 qtrs — |
| 34 | MILLENNIUM MANAGEMENT LLC | 560.7K +310.6K (+124.2%) | 1.89M +1.6M (+476.7%) | 0.35% +0.191 pp | 0.00% +0.001 pp | USD2.75 +22.5% | 57 qtrs — |
| 35 | WALLEYE CAPITAL LLC | 527.9K +527.9K (+100.0%) | 1.78M +1.8M (+100.0%) | 0.33% +0.326 pp | 0.01% +0.006 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 36 | UBS GROUP AG | 510.5K -301.1K (-37.1%) | 1.72M +657.3K (+61.8%) | 0.31% -0.187 pp | 0.00% +0.000 pp | USD1.97 +71.1% | 45 qtrs — |
| 37 | BANK OF NEW YORK MELLON CORP | 510.2K +7.1K (+1.4%) | 1.72M +1.1M (+160.9%) | 0.31% +0.004 pp | 0.00% +0.000 pp | USD11.34 -70.3% | 64 qtrs — |
| 38 | WELLINGTON MANAGEMENT GROUP LLP | 503.9K +503.9K (+100.0%) | 1.70M +1.7M (+100.0%) | 0.31% +0.311 pp | 0.00% +0.000 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 39 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 496.0K +346.0K (+230.7%) | 1.67M +1.5M (+750.6%) | 0.31% +0.213 pp | 0.04% +0.031 pp | USD3.15 +7.0% | 8 qtrs — |
| 40 | INVESCO LTD. | 449.2K +82.7K (+22.6%) | 1.51M +1.0M (+215.3%) | 0.28% +0.050 pp | 0.00% +0.000 pp | USD5.64 -40.2% | 30 qtrs — |
| 41 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 448.8K +351.9K (+363.3%) | 1.51M +1.4M (+1,091.9%) | 0.28% +0.217 pp | 0.00% +0.000 pp | USD3.28 +2.7% | 27 qtrs — |
| 42 | RANGE FINANCIAL GROUP LLC | 426.1K +426.1K (+100.0%) | 1.44M +1.4M (+100.0%) | 0.26% +0.263 pp | 0.50% +0.497 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 43 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 412.1K +412.1K (+100.0%) | 1.39M +1.4M (+100.0%) | 0.25% +0.254 pp | 0.00% +0.001 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 44 | BARCLAYS PLC | 392.9K -23.4K (-5.6%) | 1.32M -391.2K (-22.8%) | 0.24% -0.015 pp | 0.00% 0.000 pp | USD5.84 -42.3% | 51 qtrs — |
| 45 | FRANKLIN RESOURCES INC | 385.6K +362.3K (+1,558.4%) | 1.30M +1.3M (+4,166.1%) | 0.24% +0.223 pp | 0.00% +0.000 pp | USD3.70 -8.9% | 17 qtrs — |
| 46 | ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 343.0K +— (+0.0%) | 1.16M +706.6K (+157.3%) | 0.21% -0.001 pp | 0.00% +0.001 pp | USD4.58 -26.4% | 12 qtrs — |
| 47 | CERITY PARTNERS LLC | 338.5K -536.0 (-0.2%) | 1.14M +696.6K (+156.8%) | 0.21% -0.001 pp | 0.00% +0.001 pp | USD0.93 +262.4% | 4 qtrs — |
| 48 | DIMENSIONAL FUND ADVISORS LP | 330.8K +240.5K (+266.1%) | 1.11M +996.5K (+841.7%) | 0.20% +0.148 pp | 0.00% +0.000 pp | USD5.03 -33.0% | 25 qtrs — |
| 49 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 290.3K +290.3K (+100.0%) | 978.2K +978.2K (+100.0%) | 0.18% +0.179 pp | 0.01% +0.005 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 50 | LOS ANGELES CAPITAL MANAGEMENT LLC | 634.3K -495.7K (-43.9%) | 951.5K -528.9K (-35.7%) | 0.39% -0.308 pp | 0.00% -0.002 pp | USD2.01 +67.7% | 28 qtrs — |
| 51 | RUSSELL INVESTMENTS GROUP, LTD. | 265.4K -61.2K (-18.7%) | 893.7K +464.4K (+108.2%) | 0.16% -0.038 pp | 0.00% +0.001 pp | USD6.36 -47.0% | 27 qtrs — |
| 52 | CWM, LLC | 233.0K +194.0 (+0.1%) | 785.0K +480.0K (+157.4%) | 0.14% 0.000 pp | 0.00% +0.001 pp | USD1.17 +188.0% | 15 qtrs — |
| 53 | CITADEL ADVISORS LLC | 224.0K -420.1K (-65.2%) | 754.8K -88.9K (-10.5%) | 0.14% -0.260 pp | 0.00% +0.000 pp | USD3.17 +6.3% | 32 qtrs — |
| 54 | OMERS ADMINISTRATION CORP | 215.1K +— (+0.0%) | 724.9K +443.1K (+157.3%) | 0.13% 0.000 pp | 0.01% +0.003 pp | USD6.52 -48.3% | 7 qtrs — |
| 55 | JPMORGAN CHASE & CO | 214.6K +102.5K (+91.3%) | 723.2K +576.3K (+392.2%) | 0.13% +0.063 pp | 0.00% +0.000 pp | USD3.85 -12.5% | 51 qtrs — |
| 56 | RHUMBLINE ADVISERS | 199.9K -23.3K (-10.4%) | 673.7K +381.3K (+130.4%) | 0.12% -0.015 pp | 0.00% +0.000 pp | USD10.36 -67.5% | 51 qtrs — |
| 57 | ALLIANCEBERNSTEIN L.P. | 199.5K +— (+0.0%) | 672.4K +411.0K (+157.3%) | 0.12% 0.000 pp | 0.00% +0.000 pp | USD10.19 -66.9% | 61 qtrs — |
| 58 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 155.5K +1.1K (+0.7%) | 664.9K +430.3K (+183.3%) | 0.10% +0.000 pp | 0.00% +0.001 pp | USD1.21 +178.5% | 7 qtrs — |
| 59 | HENNION & WALSH ASSET MANAGEMENT, INC. | 196.0K +26.5K (+15.7%) | 660.6K +438.6K (+197.5%) | 0.12% +0.016 pp | 0.02% +0.015 pp | USD5.69 -40.8% | 11 qtrs — |
| 60 | CANADA PENSION PLAN INVESTMENT BOARD | 188.0K +188.0K (+100.0%) | 633.6K +633.6K (+100.0%) | 0.12% +0.116 pp | 0.00% +0.000 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 61 | PERSISTENT ASSET PARTNERS LTD | 182.0K +182.0K (+100.0%) | 613.5K +613.5K (+100.0%) | 0.11% +0.112 pp | 0.28% +0.276 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 62 | STATE OF WISCONSIN INVESTMENT BOARD | 180.0K +180.0K (+100.0%) | 606.7K +606.7K (+100.0%) | 0.11% +0.111 pp | 0.00% +0.001 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 63 | WELLS FARGO & COMPANY/MN | 176.6K +75.3K (+74.4%) | 595.1K +462.4K (+348.6%) | 0.11% +0.046 pp | 0.00% +0.000 pp | USD5.70 -40.9% | 57 qtrs — |
| 64 | KLP KAPITALFORVALTNING AS | 174.2K +— (+0.0%) | 587.1K +358.9K (+157.3%) | 0.11% 0.000 pp | 0.00% +0.001 pp | USD1.83 +84.2% | 5 qtrs — |
| 65 | WINTON GROUP LTD | 164.3K +164.3K (+100.0%) | 553.8K +553.8K (+100.0%) | 0.10% +0.101 pp | 0.02% +0.019 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 66 | CREATIVE PLANNING | 162.1K +71.9K (+79.8%) | 546.2K +428.1K (+362.5%) | 0.10% +0.044 pp | 0.00% +0.000 pp | USD5.12 -34.2% | 19 qtrs — |
| 67 | STATE OF WYOMING | 157.3K -205.1K (-56.6%) | 530.2K +55.4K (+11.7%) | 0.10% -0.127 pp | 0.06% +0.004 pp | USD1.87 +80.2% | 20 qtrs — |
| 68 | PRUDENTIAL FINANCIAL INC | 141.1K +91.2K (+182.6%) | 475.6K +410.2K (+627.1%) | 0.09% +0.056 pp | 0.00% +0.001 pp | USD3.46 -2.6% | 53 qtrs — |
| 69 | NUVEEN, LLC | 139.5K +139.5K (+100.0%) | 470.1K +470.1K (+100.0%) | 0.09% +0.086 pp | 0.00% +0.000 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 70 | PRELUDE CAPITAL MANAGEMENT, LLC | 136.5K +136.5K (+100.0%) | 460.0K +460.0K (+100.0%) | 0.08% +0.084 pp | 0.03% +0.034 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 71 | AMERIPRISE FINANCIAL INC | 120.0K +— (+0.0%) | 404.3K +247.1K (+157.3%) | 0.07% 0.000 pp | 0.00% +0.000 pp | USD5.22 -35.4% | 20 qtrs — |
| 72 | QUANTINNO CAPITAL MANAGEMENT LP | 118.9K +118.9K (+100.0%) | 400.7K +400.7K (+100.0%) | 0.07% +0.073 pp | 0.00% +0.001 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 73 | D. E. SHAW & CO., INC. | 117.4K -254.8K (-68.5%) | 395.8K -91.9K (-18.8%) | 0.07% -0.158 pp | 0.00% 0.000 pp | USD1.11 +203.6% | 62 qtrs — |
| 74 | MARINER, LLC | 114.1K +12.8K (+12.6%) | 384.2K +251.5K (+189.5%) | 0.07% +0.008 pp | 0.00% +0.000 pp | USD2.32 +45.3% | 16 qtrs — |
| 75 | INTEGRATED QUANTITATIVE INVESTMENTS LLC | 102.7K +102.7K (+100.0%) | 345.9K +345.9K (+100.0%) | 0.06% +0.063 pp | 0.07% +0.074 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 76 | CERCANO MANAGEMENT LLC | 101.4K +— (+0.0%) | 341.6K +208.8K (+157.3%) | 0.06% 0.000 pp | 0.01% +0.008 pp | USD4.12 -18.2% | 6 qtrs — |
| 77 | PRICE T ROWE ASSOCIATES INC /MD/ | 99.4K +19.2K (+23.9%) | 335.0K +229.0K (+216.0%) | 0.06% +0.012 pp | 0.00% +0.000 pp | USD6.37 -47.1% | 62 qtrs — |
| 78 | SQUAREPOINT OPS LLC | 88.9K +68.6K (+338.5%) | 299.5K +273.0K (+1,028.2%) | 0.05% +0.042 pp | 0.00% +0.000 pp | USD2.77 +21.7% | 3 qtrs — |
| 79 | PALLAS CAPITAL ADVISORS LLC | 88.0K +406.0 (+0.5%) | 296.5K +181.8K (+158.4%) | 0.05% +0.000 pp | 0.01% +0.006 pp | USD0.91 +270.3% | 4 qtrs — |
| 80 | METLIFE INVESTMENT MANAGEMENT, LLC | 87.5K +29.5K (+50.9%) | 294.9K +219.0K (+288.1%) | 0.05% +0.018 pp | 0.00% +0.001 pp | USD2.00 +68.5% | 33 qtrs — |
| 81 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 79.0K -45.9K (-36.7%) | 266.3K +102.7K (+62.8%) | 0.05% -0.029 pp | 0.00% +0.000 pp | USD3.66 -7.9% | 5 qtrs — |
| 82 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 78.1K +5.1K (+7.0%) | 263.1K +167.5K (+175.2%) | 0.05% +0.003 pp | 0.00% +0.000 pp | USD5.90 -42.9% | 7 qtrs — |
| 83 | MERCER GLOBAL ADVISORS INC /ADV | 77.0K +5.6K (+7.8%) | 259.3K +165.9K (+177.4%) | 0.05% +0.003 pp | 0.00% +0.000 pp | USD1.20 +180.8% | 3 qtrs — |
| 84 | STRS OHIO | 76.6K +— (+0.0%) | 258.1K +157.8K (+157.3%) | 0.05% 0.000 pp | 0.00% +0.001 pp | USD8.52 -60.4% | 8 qtrs — |
| 85 | EXCHANGE TRADED CONCEPTS, LLC | 76.6K -119.2K (-60.9%) | 258.0K +1.6K (+0.6%) | 0.05% -0.074 pp | 0.00% 0.000 pp | USD1.62 +108.0% | 6 qtrs — |
| 86 | — | 75.6K +75.6K (+100.0%) | 254.7K +254.7K (+100.0%) | 0.05% +0.047 pp | 0.09% +0.089 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 87 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 74.8K +2.1K (+2.9%) | 252.2K +157.0K (+164.8%) | 0.05% +0.001 pp | 0.00% +0.002 pp | USD0.97 +247.4% | 3 qtrs — |
| 88 | VIRTUS INVESTMENT ADVISERS, INC. | 74.3K +74.3K (+100.0%) | 250.4K +250.4K (+100.0%) | 0.05% +0.046 pp | 0.07% +0.068 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 89 | INTECH INVESTMENT MANAGEMENT LLC | 71.6K -621.0 (-0.9%) | 241.2K +146.6K (+155.0%) | 0.04% -0.001 pp | 0.00% +0.001 pp | USD3.24 +4.0% | 6 qtrs — |
| 90 | CIBC WORLD MARKET INC. | 71.3K +71.3K (+100.0%) | 240.4K +240.4K (+100.0%) | 0.04% +0.044 pp | 0.00% +0.000 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 91 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 67.9K +7.1K (+11.7%) | 228.8K +149.2K (+187.4%) | 0.04% +0.004 pp | 0.00% +0.001 pp | USD2.19 +53.9% | 10 qtrs — |
| 92 | SCOTIA CAPITAL INC. | 67.2K +67.2K (+100.0%) | 226.4K +226.4K (+100.0%) | 0.04% +0.041 pp | 0.00% +0.001 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 93 | ENTRYPOINT CAPITAL, LLC | 66.6K +66.6K (+100.0%) | 224.5K +224.5K (+100.0%) | 0.04% +0.041 pp | 0.09% +0.088 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 94 | BALYASNY ASSET MANAGEMENT L.P. | 65.2K +65.2K (+100.0%) | 219.6K +219.6K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.000 pp | USD3.37 +0.0% | 4 qtrs — |
| 95 | RAFFERTY ASSET MANAGEMENT, LLC | 64.8K +64.8K (+100.0%) | 218.5K +218.5K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.001 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 96 | CAPTRUST FINANCIAL ADVISORS | 63.8K +668.0 (+1.1%) | 215.1K +132.3K (+160.0%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD0.92 +266.3% | 9 qtrs — |
| 97 | WEDBUSH SECURITIES INC | 63.7K +63.7K (+100.0%) | 215.0K +215.0K (+100.0%) | 0.04% +0.039 pp | 0.01% +0.006 pp | USD3.37 +0.0% | 1 qtrs NEW |
| 98 | OPTIMIST RETIREMENT GROUP LLC | 59.9K +59.9K (+100.0%) | 201.9K +201.9K (+100.0%) | 0.04% +0.037 pp | 0.09% +0.093 pp | USD3.37 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.57
Neutral
Ratio by volume
0.16
Bearish
Buys
8
Sells
14
Shares acquired
1.14M
Shares disposed
7.08M
Cash buys
—
Cash sales
15.00
Net activity
-5,942,523
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | DENNER ALEXANDER J | Director | S-Sale | D | Class A Common Stock | 6,725,000 | 3.05 | 20.51M | 9,194,435 | I | ↗ |
| 2026-03-13 | DENNER ALEXANDER J | Director | A-Award | A | Class A Common Stock | 4,451 | 0.00 | — | 256,309 | D | ↗ |
| 2026-03-10 | Silver Ronald | Officer | A-Award | A | Class A Common Stock | 163,934 | 0.00 | — | 416,570 | D | ↗ |
| 2026-03-10 | Shetzline Michael | Officer | A-Award | A | Class A Common Stock | 136,612 | 0.00 | — | 658,037 | D | ↗ |
| 2026-03-10 | Martini Gregory S. | Officer | A-Award | A | Class A Common Stock | 136,612 | 0.00 | — | 297,213 | D | ↗ |
| 2026-03-10 | MCCOURT Thomas A | Director / Officer | A-Award | A | Class A Common Stock | 409,836 | 0.00 | — | 1,898,838 | D | ↗ |
| 2026-03-10 | John Minardo | Officer | A-Award | A | Class A Common Stock | 136,612 | 0.00 | — | 500,498 | D | ↗ |
| 2026-03-10 | Gaskins Tammi L | Officer | A-Award | A | Class A Common Stock | 136,612 | 0.00 | — | 350,350 | D | ↗ |
| 2026-02-24 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 12,621 | 3.66 | 46.2K | 252,636 | D | ↗ |
| 2026-02-24 | Shetzline Michael | Officer | S-Sale | A | Common Stock | 17,012 | 3.66 | 62.3K | 521,425 | D | ↗ |
| 2026-02-24 | Martini Gregory S. | Officer | S-Sale | D | Class A Common Stock | 11,457 | 3.66 | 41.9K | 160,601 | D | ↗ |
| 2026-02-24 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 103,526 | 3.66 | 378.9K | 1,489,002 | D | ↗ |
| 2026-02-24 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 19,053 | 3.66 | 69.7K | 363,886 | D | ↗ |
| 2026-02-24 | Gaskins Tammi L | Officer | S-Sale | D | Class A Common Stock | 11,239 | 3.66 | 41.1K | 213,738 | D | ↗ |
| 2026-02-23 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 11,552 | 3.81 | 44.0K | 265,257 | D | ↗ |
| 2026-02-23 | Shetzline Michael | Officer | S-Sale | D | Class A Common Stock | 15,570 | 3.81 | 59.3K | 538,437 | D | ↗ |
| 2026-02-23 | Martini Gregory S. | Officer | S-Sale | D | Class A Common Stock | 10,487 | 3.81 | 40.0K | 172,058 | D | ↗ |
| 2026-02-23 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 94,757 | 3.81 | 361.0K | 1,592,528 | D | ↗ |
| 2026-02-23 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 17,439 | 3.81 | 66.4K | 382,939 | D | ↗ |
| 2026-02-23 | Gaskins Tammi L | Officer | S-Sale | D | Class A Common Stock | 10,287 | 3.81 | 39.2K | 224,977 | D | ↗ |
| 2026-01-05 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 35,416 | 4.60 | 162.9K | 276,809 | D | ↗ |
| 2025-12-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 4,178 | 0.00 | — | 251,858 | D | ↗ |
| 2025-11-17 | Gaskins Tammi L | Officer | S-Sale | D | Class A Common Stock | 6,016 | 3.32 | 20.0K | 235,264 | D | ↗ |
| 2025-09-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 11,718 | 0.00 | — | 247,680 | D | ↗ |
| 2025-08-11 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 2,846 | 0.84 | 2.4K | 276,809 | D | ↗ |
| 2025-08-11 | Martini Gregory S. | Officer | S-Sale | D | Class A Common Stock | 1,265 | 0.84 | 1.1K | 182,545 | D | ↗ |
| 2025-08-11 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 7,754 | 0.84 | 6.5K | 400,378 | D | ↗ |
| 2025-08-11 | Gaskins Tammi L | Officer | S-Sale | D | Class A Common Stock | 1,316 | 0.84 | 1.1K | 241,280 | D | ↗ |
| 2025-06-13 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 24,193 | 0.00 | — | 235,962 | D | ↗ |
| 2025-06-10 | Shepard Jay | Director | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 171,555 | D | ↗ |
| 2025-06-10 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 117,944 | D | ↗ |
| 2025-06-10 | McHugh Julie | Director | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 208,839 | D | ↗ |
| 2025-06-10 | Kessler Marla L | Director | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 165,883 | D | ↗ |
| 2025-06-10 | Duane Jon R | Director | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 190,339 | D | ↗ |
| 2025-06-10 | Dreyfus Andrew | Director | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 228,313 | D | ↗ |
| 2025-06-10 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 211,769 | D | ↗ |
| 2025-06-10 | Currie Mark G | Director | A-Award | A | Class A Common Stock | 45,000 | 0.00 | — | 613,419 | D | ↗ |
| 2025-05-20 | MCCOURT Thomas A | Director / Officer | A-Award | A | Class A Common Stock | 540,000 | 0.00 | — | 1,687,281 | D | ↗ |
| 2025-05-16 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 13,353 | 0.58 | 7.7K | 1,147,281 | D | ↗ |
| 2025-05-16 | Gaskins Tammi L | Officer | S-Sale | D | Class A Common Stock | 2,563 | 0.58 | 1.5K | 242,596 | D | ↗ |
| 2025-04-02 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 10,416 | 0.00 | — | 166,769 | D | ↗ |
| 2025-03-11 | Gaskins Tammi L | Officer | — | — | Class A Common Stock | 0 | 0.00 | — | 245,159 | D | ↗ |
| 2025-02-10 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 12,048 | 1.76 | 21.2K | 279,655 | D | ↗ |
| 2025-02-10 | Shetzline Michael | Officer | A-Award | A | Class A Common Stock | 133,333 | 0.00 | — | 595,276 | D | ↗ |
| 2025-02-10 | Martini Gregory S. | Officer | S-Sale | D | Class A Common Stock | 12,052 | 1.76 | 21.2K | 183,810 | D | ↗ |
| 2025-02-10 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 139,064 | 1.76 | 244.8K | 1,160,634 | D | ↗ |
| 2025-02-10 | John Minardo | Officer | A-Award | A | Class A Common Stock | 122,222 | 0.00 | — | 447,070 | D | ↗ |
| 2025-01-27 | Silver Ronald | Officer | A-Award | A | Class A Common Stock | 133,333 | 0.00 | — | 291,703 | D | ↗ |
| 2025-01-27 | Martini Gregory S. | Officer | — | — | Employee Stock Options (Right to Buy) | 1,587 | 12.95 | 20.6K | 0 | D | ↗ |
| 2025-01-17 | Shetzline Michael | Officer | A-Award | A | Class A Common Stock | 48,224 | 0.00 | — | 461,943 | D | ↗ |
| 2025-01-17 | MCCOURT Thomas A | Director / Officer | A-Award | A | Class A Common Stock | 147,354 | 0.00 | — | 1,299,698 | D | ↗ |
| 2025-01-17 | John Minardo | Officer | A-Award | A | Class A Common Stock | 40,187 | 0.00 | — | 324,848 | D | ↗ |
| 2024-12-16 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 4,249 | 0.00 | — | 156,353 | D | ↗ |
| 2024-11-18 | Emany Sravan Kumar | Officer | S-Sale | D | Class A Common Stock | 11,001 | 4.08 | 44.9K | 309,572 | D | ↗ |
| 2024-11-18 | Davis Andrew | Officer | S-Sale | D | Class A Common Stock | 5,360 | 4.08 | 21.9K | 284,685 | D | ↗ |
| 2024-09-16 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 3,282 | 0.00 | — | 152,104 | — | ↗ |
| 2024-08-12 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 3,107 | 4.27 | 13.3K | 158,370 | — | ↗ |
| 2024-08-12 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 9,910 | 4.27 | 42.3K | 284,661 | — | ↗ |
| 2024-06-18 | Shepard Jay | Director | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 126,555 | — | ↗ |
| 2024-06-18 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 72,944 | — | ↗ |
| 2024-06-18 | McHugh Julie | Director | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 163,839 | — | ↗ |
| 2024-06-18 | Kessler Marla L | Director | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 120,883 | — | ↗ |
| 2024-06-18 | Duane Jon R | Director | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 145,339 | — | ↗ |
| 2024-06-18 | Dreyfus Andrew | Director | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 188,230 | — | ↗ |
| 2024-06-18 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 148,822 | — | ↗ |
| 2024-06-18 | Currie Mark G | Director | A-Award | A | Class A Common Stock | 24,311 | 0.00 | — | 568,419 | — | ↗ |
| 2024-06-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 2,572 | 0.00 | — | 124,511 | — | ↗ |
| 2024-06-10 | McHugh Julie | Director | S-Sale | D | Class A Common Stock | 22,766 | 6.29 | 143.2K | 139,528 | — | ↗ |
| 2024-06-07 | Moukheibir Catherine | Director | S-Sale | D | Class A Common Stock | 35,574 | 6.61 | 235.1K | 48,633 | — | ↗ |
| 2024-06-06 | Moukheibir Catherine | Director | S-Sale | D | Class A Common Stock | 44,426 | 6.36 | 282.5K | 84,207 | — | ↗ |
| 2024-05-20 | Shetzline Michael | Officer | S-Sale | D | Class A Common Stock | 16,128 | 6.45 | 104.0K | 413,719 | — | ↗ |
| 2024-05-20 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 67,618 | 6.45 | 436.1K | 1,150,330 | — | ↗ |
| 2024-05-20 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 17,404 | 6.45 | 112.3K | 294,571 | — | ↗ |
| 2024-05-20 | Davis Andrew | Officer | S-Sale | D | Class A Common Stock | 22,725 | 6.45 | 146.6K | 288,031 | — | ↗ |
| 2024-05-16 | Emany Sravan Kumar | Officer | F-InKind | D | Class A Common Stock | 18,280 | 6.64 | 121.4K | 320,573 | — | ↗ |
| 2024-03-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,662 | 0.00 | — | 121,939 | — | ↗ |
| 2024-03-08 | Shetzline Michael | Officer | M-Exempt | D | Performance-based Restricted Stock Unit | 34,936 | 0.00 | — | 0 | — | ↗ |
| 2024-03-08 | MCCOURT Thomas A | Director / Officer | M-Exempt | A | Class A Common Stock | 120,298 | 0.00 | — | 1,217,948 | — | ↗ |
| 2024-03-08 | John Minardo | Officer | M-Exempt | D | Performance-based Restricted Stock Unit | 32,752 | 0.00 | — | 0 | — | ↗ |
| 2024-03-08 | Emany Sravan Kumar | Officer | M-Exempt | A | Class A Common Stock | 37,120 | 0.00 | — | 338,853 | — | ↗ |
| 2024-03-08 | Davis Andrew | Officer | M-Exempt | D | Performance-based Restricted Stock Unit | 37,120 | 0.00 | — | 0 | — | ↗ |
| 2024-03-06 | Duane Jon R | Director | P-Purchase | A | Class A Common Stock | 6,920 | 8.70 | 60.2K | 121,028 | — | ↗ |
| 2024-03-05 | MCCOURT Thomas A | Director / Officer | A-Award | A | Class A Common Stock | 264,876 | 0.00 | — | 1,097,650 | — | ↗ |
| 2024-03-04 | Emany Sravan Kumar | Officer | P-Purchase | A | Class A Common Stock | 10,684 | 9.38 | 100.2K | 301,733 | — | ↗ |
| 2024-02-12 | Silver Ronald | Officer | A-Award | A | Class A Common Stock | 27,213 | 0.00 | — | 161,477 | — | ↗ |
| 2024-02-12 | Shetzline Michael | Officer | A-Award | A | Performance-based Restricted Stock Unit | 27,214 | 0.00 | — | 27,214 | — | ↗ |
| 2024-02-12 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 177,164 | 15.24 | 2.70M | 832,774 | — | ↗ |
| 2024-02-12 | John Minardo | Officer | A-Award | A | Performance-based Restricted Stock Unit | 27,214 | 0.00 | — | 27,214 | — | ↗ |
| 2024-02-12 | Emany Sravan Kumar | Officer | A-Award | A | Class A Common Stock | 65,312 | 0.00 | — | 291,049 | — | ↗ |
| 2024-02-12 | Davis Andrew | Officer | A-Award | A | Performance-based Restricted Stock Unit | 32,656 | 0.00 | — | 32,656 | — | ↗ |
| 2024-02-08 | Emany Sravan Kumar | Officer | F-InKind | D | Class A Common Stock | 41,332 | 14.90 | 615.8K | 225,737 | — | ↗ |
| 2024-01-17 | Shetzline Michael | Officer | A-Award | A | Class A Common Stock | 57,971 | 0.00 | — | 379,102 | — | ↗ |
| 2024-01-17 | MCCOURT Thomas A | Director / Officer | A-Award | A | Class A Common Stock | 249,617 | 0.00 | — | 1,009,938 | — | ↗ |
| 2024-01-17 | John Minardo | Officer | A-Award | A | Class A Common Stock | 79,981 | 0.00 | — | 272,176 | — | ↗ |
| 2024-01-17 | Emany Sravan Kumar | Officer | A-Award | A | Class A Common Stock | 85,000 | 0.00 | — | 267,069 | — | ↗ |
| 2023-12-15 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 1,572 | 0.00 | — | 128,633 | — | ↗ |
| 2023-12-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,347 | 0.00 | — | 120,277 | — | ↗ |
| 2023-12-14 | Kessler Marla L | Director | S-Sale | D | Class A Common Stock | 9,926 | 11.19 | 111.1K | 96,572 | — | ↗ |
| 2023-11-20 | Davis Andrew | Officer | S-Sale | D | Class A Common Stock | 3,287 | 9.69 | 31.9K | 217,374 | — | ↗ |
| 2023-11-16 | Emany Sravan Kumar | Officer | F-InKind | D | Class A Common Stock | 6,661 | 9.44 | 62.9K | 182,069 | — | ↗ |
| 2023-09-15 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 2,098 | 0.00 | — | 127,061 | — | ↗ |
| 2023-09-15 | Emany Sravan Kumar | Officer | P-Purchase | A | Class A Common Stock | 36,072 | 8.32 | 300.1K | 188,730 | — | ↗ |
| 2023-09-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,798 | 0.00 | — | 118,930 | — | ↗ |
| 2023-08-29 | Silver Ronald | Officer | A-Award | A | Class A Common Stock | 8,000 | 0.00 | — | 142,172 | — | ↗ |
| 2023-08-14 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 1,976 | 10.04 | 19.8K | 134,172 | — | ↗ |
| 2023-08-14 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 7,045 | 10.04 | 70.7K | 192,195 | — | ↗ |
| 2023-06-20 | Shepard Jay | Director | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 102,244 | — | ↗ |
| 2023-06-20 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 124,963 | — | ↗ |
| 2023-06-20 | McHugh Julie | Director | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 162,294 | — | ↗ |
| 2023-06-20 | Kessler Marla L | Director | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 106,498 | — | ↗ |
| 2023-06-20 | Duane Jon R | Director | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 114,108 | — | ↗ |
| 2023-06-20 | Dreyfus Andrew | Director | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 168,980 | — | ↗ |
| 2023-06-20 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 117,132 | — | ↗ |
| 2023-06-20 | Currie Mark G | Director | A-Award | A | Class A Common Stock | 22,350 | 0.00 | — | 544,108 | — | ↗ |
| 2023-06-15 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 1,586 | 0.00 | — | 102,613 | — | ↗ |
| 2023-06-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,359 | 0.00 | — | 94,782 | — | ↗ |
| 2023-05-30 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 26,632 | 10.70 | 285.0K | 758,284 | — | ↗ |
| 2023-05-22 | Shetzline Michael | Officer | S-Sale | D | Class A Common Stock | 10,324 | 10.12 | 104.5K | 321,131 | — | ↗ |
| 2023-05-22 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 36,000 | 10.12 | 364.3K | 784,916 | — | ↗ |
| 2023-05-22 | Davis Andrew | Officer | S-Sale | D | Class A Common Stock | 6,305 | 10.12 | 63.8K | 219,327 | — | ↗ |
| 2023-05-08 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 21,148 | 10.62 | 224.6K | 820,916 | — | ↗ |
| 2023-03-27 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 46,129 | 10.67 | 492.2K | 842,064 | — | ↗ |
| 2023-03-15 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 1,677 | 0.00 | — | 101,027 | — | ↗ |
| 2023-03-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,438 | 0.00 | — | 93,423 | — | ↗ |
| 2023-03-08 | Silver Ronald | Officer | A-Award | A | Class A Common Stock | 35,620 | 0.00 | — | 134,111 | — | ↗ |
| 2023-03-08 | Shetzline Michael | Officer | A-Award | A | Performance-based Restricted Stock Units | 34,935 | 0.00 | — | 34,935 | — | ↗ |
| 2023-03-08 | Rickard Jason | Officer | A-Award | A | Performance-based Restricted Stock Units | 21,834 | 0.00 | — | 21,834 | — | ↗ |
| 2023-03-08 | MCCOURT Thomas A | Director / Officer | A-Award | A | Performance-based Restricted Stock Units | 120,297 | 0.00 | — | 120,297 | — | ↗ |
| 2023-03-08 | John Minardo | Officer | A-Award | A | Performance-based Restricted Stock Units | 32,751 | 0.00 | — | 32,751 | — | ↗ |
| 2023-03-08 | Emany Sravan Kumar | Officer | A-Award | A | Performance-based Restricted Stock Units | 37,118 | 0.00 | — | 37,118 | — | ↗ |
| 2023-03-08 | Davis Andrew | Officer | A-Award | A | Class A Common Stock | 74,236 | 0.00 | — | 225,632 | — | ↗ |
| 2023-03-03 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 33,756 | 11.22 | 378.7K | 647,598 | — | ↗ |
| 2023-02-28 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 3,049 | 11.31 | 34.5K | 98,491 | — | ↗ |
| 2023-02-28 | Shetzline Michael | Officer | S-Sale | D | Class A Common Stock | 7,438 | 11.31 | 84.1K | 264,002 | — | ↗ |
| 2023-02-28 | Rickard Jason | Officer | S-Sale | D | Class A Common Stock | 13,987 | 11.31 | 158.2K | 336,090 | — | ↗ |
| 2023-02-28 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 26,639 | 11.31 | 301.3K | 685,942 | — | ↗ |
| 2023-02-28 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 3,415 | 11.31 | 38.6K | 133,738 | — | ↗ |
| 2023-02-28 | Davis Andrew | Officer | S-Sale | D | Class A Common Stock | 1,822 | 11.31 | 20.6K | 151,396 | — | ↗ |
| 2023-02-27 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 2,929 | 11.41 | 33.4K | 101,540 | — | ↗ |
| 2023-02-27 | Shetzline Michael | Officer | S-Sale | D | Class A Common Stock | 2,322 | 11.41 | 26.5K | 271,440 | — | ↗ |
| 2023-02-27 | Rickard Jason | Officer | S-Sale | D | Class A Common Stock | 3,308 | 11.41 | 37.7K | 350,077 | — | ↗ |
| 2023-02-27 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 25,595 | 11.41 | 292.0K | 716,990 | — | ↗ |
| 2023-02-27 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 3,282 | 11.41 | 37.4K | 137,153 | — | ↗ |
| 2023-02-27 | Davis Andrew | Officer | S-Sale | D | Class A Common Stock | 1,751 | 11.41 | 20.0K | 153,218 | — | ↗ |
| 2023-01-17 | Shetzline Michael | Officer | A-Award | A | Class A Common Stock | 14,663 | 0.00 | — | 280,908 | — | ↗ |
| 2023-01-17 | Rickard Jason | Officer | A-Award | A | Class A Common Stock | 18,087 | 0.00 | — | 366,823 | — | ↗ |
| 2023-01-17 | MCCOURT Thomas A | Officer | A-Award | A | Class A Common Stock | 30,145 | 0.00 | — | 742,585 | — | ↗ |
| 2023-01-05 | MCCOURT Thomas A | Officer | M-Exempt | D | Employee Stock Options (Right to Buy) | 110,962 | 0.00 | — | 0 | — | ↗ |
| 2022-12-15 | DENNER ALEXANDER J | Director | A-Award | A | Class A Common Stock | 1,244 | 0.00 | — | 91,985 | — | ↗ |
| 2022-12-14 | Rickard Jason | Officer | S-Sale | D | Class A Common Stock | 27,000 | 12.39 | 334.5K | 348,736 | — | ↗ |
| 2022-11-21 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 682 | 11.56 | 7.9K | 104,469 | — | ↗ |
| 2022-11-21 | Emany Sravan Kumar | Officer | S-Sale | D | Class A Common Stock | 6,578 | 11.56 | 76.0K | 78,422 | — | ↗ |
| 2022-11-21 | Davis Andrew | Officer | S-Sale | D | Class A Common Stock | 3,335 | 11.56 | 38.6K | 154,213 | — | ↗ |
| 2022-10-03 | MCCOURT Thomas A | Officer | S-Sale | D | Class A Common Stock | 18,899 | 10.41 | 196.7K | 712,440 | — | ↗ |
| 2022-09-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,374 | 0.00 | — | 90,741 | — | ↗ |
| 2022-09-01 | MCCOURT Thomas A | Officer | S-Sale | D | Class A Common Stock | 26,446 | 10.65 | 281.6K | 731,339 | — | ↗ |
| 2022-08-15 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 2,014 | 11.77 | 23.7K | 105,151 | — | ↗ |
| 2022-08-15 | Rickard Jason | Officer | S-Sale | D | Class A Common Stock | 994 | 11.77 | 11.7K | 375,736 | — | ↗ |
| 2022-08-15 | John Minardo | Officer | S-Sale | D | Class A Common Stock | 7,330 | 11.77 | 86.3K | 140,435 | — | ↗ |
| 2022-08-11 | Currie Mark G | Director | S-Sale | D | Class A Common Stock | 70,000 | 11.78 | 824.6K | 521,758 | — | ↗ |
| 2022-08-09 | Rickard Jason | Officer | M-Exempt | A | Class A Common Stock | 18,041 | 11.65 | 210.2K | 394,771 | — | ↗ |
| 2022-08-08 | Rickard Jason | Officer | S-Sale | D | Class A Common Stock | 27,200 | 11.64 | 316.6K | 378,966 | — | ↗ |
| 2022-08-01 | MCCOURT Thomas A | Officer | S-Sale | D | Class A Common Stock | 23,229 | 11.35 | 263.6K | 757,785 | — | ↗ |
| 2022-06-30 | MCCOURT Thomas A | Officer | S-Sale | D | Class A Common Stock | 19,959 | 11.58 | 231.1K | 778,922 | — | ↗ |
| 2022-06-15 | Sarissa Capital Management LP | Director | A-Award | A | Class A Common Stock | 1,222 | 0.00 | — | 89,367 | — | ↗ |
| 2022-06-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,222 | 0.00 | — | 89,367 | — | ↗ |
| 2022-06-14 | Kessler Marla L | Director | S-Sale | D | Class A Common Stock | 7,610 | 11.65 | 88.7K | 84,148 | — | ↗ |
| 2022-06-07 | Currie Mark G | Director | M-Exempt | A | Class A Common Stock | 190,383 | 11.65 | 2.22M | 782,141 | — | ↗ |
| 2022-06-01 | Shepard Jay | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 79,894 | — | ↗ |
| 2022-06-01 | Sarissa Capital Management LP | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 88,145 | — | ↗ |
| 2022-06-01 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 99,350 | — | ↗ |
| 2022-06-01 | McHugh Julie | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 139,944 | — | ↗ |
| 2022-06-01 | Kessler Marla L | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 91,758 | — | ↗ |
| 2022-06-01 | Duane Jon R | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 91,758 | — | ↗ |
| 2022-06-01 | Dreyfus Andrew | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 151,639 | — | ↗ |
| 2022-06-01 | Davis Andrew | Officer | — | D | Class A Common Stock | 0 | 0.00 | — | 156,516 | — | ↗ |
| 2022-06-01 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 88,145 | — | ↗ |
| 2022-06-01 | Currie Mark G | Director | A-Award | A | Class A Common Stock | 21,571 | 0.00 | — | 591,758 | — | ↗ |
| 2022-05-23 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 120 | 11.50 | 1.4K | 105,073 | — | ↗ |
| 2022-05-23 | Shetzline Michael | Officer | S-Sale | D | Class A Common Stock | 3,130 | 11.50 | 36.0K | 273,698 | — | ↗ |
| 2022-05-23 | Rickard Jason | Officer | S-Sale | D | Class A Common Stock | 777 | 11.50 | 8.9K | 416,834 | — | ↗ |
| 2022-05-23 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 11,848 | 11.50 | 136.3K | 798,881 | — | ↗ |
| 2022-03-24 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 3,031 | 12.75 | 38.6K | 105,193 | — | ↗ |
| 2022-03-15 | Sarissa Capital Management LP | Director | A-Award | A | Class A Common Stock | 1,152 | 0.00 | — | 66,574 | — | ↗ |
| 2022-03-15 | Moukheibir Catherine | Director | A-Award | A | Class A Common Stock | 1,466 | 0.00 | — | 77,779 | — | ↗ |
| 2022-03-15 | DENNER ALEXANDER J | Director / 10% Owner | A-Award | A | Class A Common Stock | 1,152 | 0.00 | — | 66,574 | — | ↗ |
| 2022-03-14 | McHugh Julie | Director | S-Sale | D | Class A Common Stock | 20,000 | 11.67 | 233.4K | 118,373 | — | ↗ |
| 2022-03-08 | MCCOURT Thomas A | Officer | A-Award | A | Class A Common Stock | 248,869 | 0.00 | — | 835,189 | — | ↗ |
| 2022-03-02 | Silver Ronald | Officer | A-Award | A | Class A Common Stock | 30,000 | 0.00 | — | 108,224 | — | ↗ |
| 2022-03-02 | Shetzline Michael | Officer | A-Award | A | Class A Common Stock | 81,448 | 0.00 | — | 276,828 | — | ↗ |
| 2022-03-02 | Rickard Jason | Officer | A-Award | A | Class A Common Stock | 90,498 | 0.00 | — | 417,611 | — | ↗ |
| 2022-03-02 | John Minardo | Officer | A-Award | A | Class A Common Stock | 67,873 | 0.00 | — | 147,765 | — | ↗ |
| 2022-02-28 | Silver Ronald | Officer | S-Sale | D | Class A Common Stock | 1,150 | 10.77 | 12.4K | 61,211 | — | ↗ |
| 2022-02-28 | Shetzline Michael | Officer | S-Sale | D | Class A Common Stock | 2,911 | 10.77 | 31.4K | 208,709 | — | ↗ |
| 2022-02-28 | Rickard Jason | Officer | S-Sale | D | Class A Common Stock | 11,057 | 10.77 | 119.1K | 333,933 | — | ↗ |
| 2022-02-28 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 16,486 | 10.77 | 177.6K | 586,320 | — | ↗ |
| 2022-01-19 | Shetzline Michael | Officer | A-Award | A | Class A Common Stock | 29,326 | 0.00 | — | 212,987 | — | ↗ |
| 2022-01-19 | Rickard Jason | Officer | A-Award | A | Class A Common Stock | 36,174 | 0.00 | — | 356,075 | — | ↗ |
| 2022-01-19 | MCCOURT Thomas A | Director / Officer | A-Award | A | Class A Common Stock | 60,290 | 0.00 | — | 634,744 | — | ↗ |
| 2021-12-22 | MCCOURT Thomas A | Director / Officer | S-Sale | D | Class A Common Stock | 46,327 | 11.41 | 528.6K | 574,454 | — | ↗ |
Executive team
Top executives
EBIT / Employee
406.2K
Shares Outstanding
163.06M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Thomas McCourt Chief Executive Officer | 867.6K | — | 411.7K | — | 650.7K | 18.5K | 1.95M | 21.13% | ↗ |
| 2 | 2025 | Tammi Gaskins Senior Vice President, Chief Commercial Officer | 474.7K | — | 447.8K | — | 274.4K | 18.5K | 1.22M | 36.84% | ↗ |
| 3 | 2025 | Gregory Martini Senior Vice President, Chief Financial Officer | 470.5K | — | 447.8K | — | 274.4K | 18.5K | 1.21M | 36.97% | ↗ |
| 4 | 2024 | Thomas McCourt Chief Executive Officer | 867.6K | — | 4.72M | — | 455.5K | 37.9K | 6.08M | 77.63% | ↗ |
| 5 | 2024 | Sravan Emany Former Senior Vice President, Chief Operating Officer and Chief Financial Officer | 575.1K | — | 2.38M | — | — | 14.9K | 2.97M | 80.13% | ↗ |
| 6 | 2024 | Andrew Davis Former Senior Vice President, Chief Business Officer | 470.2K | — | 2.38M | — | — | 33.8K | 2.88M | 82.52% | ↗ |
| 7 | 2024 | Michael Shetzline Senior Vice President, Chief Medical Officer, and Head of Research and Drug Development | 557.6K | — | 1.98M | — | 180.9K | 18.2K | 2.74M | 72.37% | ↗ |
| 8 | 2024 | John Minardo Senior Vice President, Chief Legal Officer and Secretary | 531.7K | — | 1.98M | — | 167.5K | 18.2K | 2.70M | 73.42% | ↗ |
| 9 | 2023 | Thomas McCourt Chief Executive Officer | 834.2K | — | 5.97M | — | 750.8K | 24.6K | 7.58M | 78.78% | ↗ |
| 10 | 2023 | Sravan Emany Former Senior Vice President, Chief Operating Officer and Chief Financial Officer | 545.0K | — | 1.84M | — | 361.3K | 17.6K | 2.76M | 66.85% | ↗ |
| 11 | 2023 | Sravan Emany Senior Vice President, Chief Financial Officer | 535.0K | — | 1.84M | — | 361.3K | 17.6K | 2.76M | 66.85% | ↗ |
| 12 | 2023 | Andrew Davis Former Senior Vice President, Chief Business Officer | 480.0K | — | 1.84M | — | 322.6K | 22.2K | 2.67M | 69.09% | ↗ |
| 13 | 2023 | Andrew Davis Senior Vice President, Chief Business Officer | 479.6K | — | 1.84M | — | 322.6K | 22.2K | 2.67M | 69.10% | ↗ |
| 14 | 2023 | Michael Shetzline Senior Vice President, Chief Medical Officer, and Head of Research and Drug Development | 533.6K | — | 1.73M | — | 309.7K | 17.6K | 2.60M | 66.84% | ↗ |
| 15 | 2023 | John Minardo Senior Vice President, Chief Legal Officer and Secretary | 514.7K | — | 1.63M | — | 284.9K | 17.6K | 2.44M | 66.56% | ↗ |
| 16 | 2022 | Thomas McCourt Chief Executive Officer | 806.0K | 143.3K | 6.47M | — | 453.4K | 18.1K | 7.89M | 82.00% | ↗ |
| 17 | 2022 | Jason Rickard Senior Vice President, Chief Operating Officer | 519.6K | 121.1K | 2.31M | — | 209.6K | 19.2K | 3.18M | 72.67% | ↗ |
| 18 | 2022 | Michael Shetzline Senior Vice President, Chief Medical Officer, and Head of Research and Drug Development | 513.0K | 121.0K | 2.08M | — | 188.7K | 15.5K | 2.92M | 71.28% | ↗ |
| 19 | 2022 | John Minardo Senior Vice President, Chief Legal Officer and Secretary | 494.0K | — | 1.73M | — | 166.7K | 15.5K | 2.41M | 71.94% | ↗ |
| 20 | 2022 | Sravan Emany Former Senior Vice President, Chief Operating Officer and Chief Financial Officer | 500.0K | — | — | — | 198.8K | 13.6K | 712.4K | 0.00% | ↗ |
| 21 | 2022 | Sravan Emany Senior Vice President, Chief Financial Officer | 500.0K | — | — | — | 198.8K | 13.6K | 712.4K | 0.00% | ↗ |
| 22 | 2021 | Thomas McCourt Chief Executive Officer | 732.1K | 143.3K | 7.24M | — | 680.1K | 18.1K | 8.81M | 82.14% | ↗ |
| 23 | 2021 | Jason Rickard Senior Vice President, Chief Operating Officer | 492.6K | 121.1K | 2.52M | — | 327.6K | 18.1K | 3.48M | 72.43% | ↗ |
| 24 | 2021 | John Minardo Senior Vice President, Chief Legal Officer and Secretary | 191.8K | 250.0K | 2.60M | — | 105.0K | 6.4K | 3.15M | 82.43% | ↗ |
| 25 | 2021 | Gina Consylman Former Senior Vice President, Chief Financial Officer | 264.3K | — | 2.52M | — | — | 8.7K | 2.79M | 90.23% | ↗ |
| 26 | 2021 | Michael Shetzline Senior Vice President, Chief Medical Officer, and Head of Research and Drug Development | 483.4K | 121.0K | 1.73M | — | 285.4K | 18.1K | 2.64M | 65.55% | ↗ |
| 27 | 2021 | Sravan Emany Senior Vice President, Chief Financial Officer | 28.8K | 200.0K | 2.30M | — | — | 46.00 | 2.53M | 90.95% | ↗ |
| 28 | 2021 | Mark Mallon Former Chief Executive Officer | 163.4K | — | — | — | — | 7.2K | 170.6K | 0.00% | ↗ |
| 29 | 2020 | Mark Mallon Former Chief Executive Officer | 801.2K | — | 5.42M | — | 585.2K | 11.0K | 6.82M | 79.51% | ↗ |
| 30 | 2020 | Thomas McCourt Chief Executive Officer | 576.1K | — | 2.47M | — | 357.4K | 11.0K | 3.41M | 72.30% | ↗ |
| 31 | 2020 | Thomas McCourt President and Interim Chief Executive Officer | 576.1K | — | 2.47M | — | 357.4K | 11.0K | 3.41M | 72.30% | ↗ |
| 32 | 2020 | Gina Consylman Chief Financial Officer and Senior Vice President | 512.8K | — | 1.68M | — | 264.7K | 11.0K | 2.46M | 68.01% | ↗ |
| 33 | 2020 | Gina Consylman Former Senior Vice President, Chief Financial Officer | 512.8K | — | 1.68M | — | 264.7K | 11.0K | 2.46M | 68.01% | ↗ |
| 34 | 2020 | Jason Rickard Chief Operating Officer and Senior Vice President | 473.3K | — | 1.48M | — | 258.3K | 11.0K | 2.22M | 66.57% | ↗ |
| 35 | 2020 | Jason Rickard Senior Vice President, Chief Operating Officer | 473.3K | — | 1.48M | — | 258.3K | 11.0K | 2.22M | 66.57% | ↗ |
| 36 | 2020 | Michael Shetzline Senior Vice President, Chief Medical Officer, and Head of Research and Drug Development | 464.7K | 100.0K | 1.12M | — | 194.6K | 11.0K | 1.89M | 59.27% | ↗ |
| 37 | 2020 | Michael Shetzline, M.D., Ph.D. Chief Medical Officer, Senior Vice President and Head of Drug Development Development | 464.7K | 100.0K | 1.12M | — | 194.6K | 11.0K | 1.89M | 59.27% | ↗ |
| 38 | 2019 | Mark Mallon Former Chief Executive Officer | 750.0K | 880.0K | 3.69M | 3.80M | 797.1K | 144.6K | 10.07M | 74.46% | ↗ |
| 39 | 2019 | Mark Mallon Chief Executive Officer | 750.0K | 880.0K | 3.69M | 3.80M | 797.1K | 144.6K | 10.07M | 74.46% | ↗ |
| 40 | 2019 | Peter M. Hecht, Ph.D. Former Chief Executive Officer | 25.0K | — | — | 6.13M | — | 6.6K | 6.16M | 99.49% | ↗ |
| 41 | 2019 | Thomas McCourt President and Interim Chief Executive Officer | 511.3K | — | 1.76M | 2.37M | 454.3K | 8.5K | 5.10M | 80.92% | ↗ |
| 42 | 2019 | Thomas McCourt Chief Executive Officer | 511.3K | — | 1.76M | 2.37M | 454.3K | 8.5K | 5.10M | 80.92% | ↗ |
| 43 | 2019 | Thomas A. McCourt President | 511.3K | — | 1.76M | 2.37M | 454.3K | 8.5K | 5.10M | 80.92% | ↗ |
| 44 | 2019 | Mark G. Currie, Ph.D. Former Senior Vice President, Chief Scientific Officer and President of R&D | 125.0K | — | 286.3K | 3.68M | — | 44.1K | 4.13M | 95.91% | ↗ |
| 45 | 2019 | Gina Consylman Former Senior Vice President, Chief Financial Officer | 480.0K | 250.0K | 1.47M | 888.5K | 358.8K | 8.5K | 3.45M | 68.23% | ↗ |
| 46 | 2019 | Gina Consylman Chief Financial Officer and Senior Vice President | 480.0K | 250.0K | 1.47M | 888.5K | 358.8K | 8.5K | 3.45M | 68.23% | ↗ |
| 47 | 2019 | Halley E. Gilbert Former Chief Administrative Officer and Senior Vice President, Corporate Development | 480.0K | 250.0K | 1.47M | 888.5K | 340.1K | 8.5K | 3.43M | 68.60% | ↗ |
| 48 | 2018 | Peter M. Hecht, Ph.D. Former Chief Executive Officer | 100.0K | 1.19M | — | 3.84M | — | 25.3K | 5.16M | 74.46% | ↗ |
| 49 | 2018 | William Huyett Former Chief Operating Officer | 465.0K | — | 1.09M | 2.35M | 232.5K | 8.0K | 4.14M | 82.97% | ↗ |
| 50 | 2018 | Mark G. Currie, Ph.D. Former Senior Vice President, Chief Scientific Officer and President of R&D | 485.0K | — | 231.4K | 1.42M | 242.5K | 62.3K | 2.45M | 67.70% | ↗ |
| 51 | 2018 | Thomas A. McCourt President | 465.0K | — | 549.6K | 869.5K | 232.5K | 34.0K | 2.15M | 65.99% | ↗ |
| 52 | 2018 | Thomas McCourt President and Interim Chief Executive Officer | 465.0K | — | 549.6K | 869.5K | 232.5K | 34.0K | 2.15M | 65.99% | ↗ |
| 53 | 2018 | Halley E. Gilbert Former Chief Administrative Officer and Senior Vice President, Corporate Development | 460.0K | — | 740.6K | 463.7K | 230.0K | 33.4K | 1.93M | 62.47% | ↗ |
| 54 | 2018 | Gina Consylman Chief Financial Officer and Senior Vice President | 415.0K | — | 782.4K | 501.8K | 207.5K | 8.0K | 1.91M | 67.07% | ↗ |
| 55 | 2017 | Peter M. Hecht, Ph.D. Former Chief Executive Officer | 100.0K | — | — | 5.89M | — | 8.0K | 6.00M | 98.20% | ↗ |
| 56 | 2017 | Mark G. Currie, Ph.D. Former Senior Vice President, Chief Scientific Officer and President of R&D | 470.0K | — | — | 1.94M | 210.0K | 8.0K | 2.62M | 73.79% | ↗ |
| 57 | 2017 | Thomas A. McCourt President | 450.0K | — | 440.2K | 1.22M | 191.0K | 8.0K | 2.31M | 71.90% | ↗ |
| 58 | 2017 | Halley E. Gilbert Former Chief Administrative Officer and Senior Vice President, Corporate Development | 440.0K | — | 670.8K | 619.7K | 195.0K | 8.0K | 1.93M | 66.74% | ↗ |
| 59 | 2017 | Gina Consylman Chief Financial Officer and Senior Vice President | 334.3K | — | 440.2K | — | 185.0K | 8.0K | 967.5K | 45.50% | ↗ |
| 60 | 2016 | Peter M. Hecht, Ph.D. Former Chief Executive Officer | 100.0K | — | — | 4.14M | — | 8.1K | 4.24M | 97.45% | ↗ |
| 61 | 2016 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | 4.14M | — | 8.1K | 4.24M | 97.45% | ↗ |
| 62 | 2016 | Mark G. Currie, Ph.D. Former Senior Vice President, Chief Scientific Officer and President of R&D | 454.0K | — | — | 1.09M | 301.0K | 8.0K | 1.86M | 58.87% | ↗ |
| 63 | 2016 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of R&D | 454.0K | — | — | 1.09M | 301.0K | 8.0K | 1.86M | 58.87% | ↗ |
| 64 | 2016 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 435.0K | — | — | 813.2K | 288.0K | 8.0K | 1.54M | 52.66% | ↗ |
| 65 | 2016 | Thomas A. McCourt President | 435.0K | — | — | 813.2K | 288.0K | 8.0K | 1.54M | 52.66% | ↗ |
| 66 | 2016 | Tom Graney Chief Financial Officer and Senior Vice President, Finance and Corporate Strategy | 435.0K | — | 179.2K | 487.9K | 257.0K | 145.6K | 1.50M | 44.34% | ↗ |
| 67 | 2016 | Halley E. Gilbert Senior Vice President, Chief Legal Officer and Secretary | 423.0K | — | 332.8K | 302.1K | 280.0K | 8.0K | 1.35M | 47.17% | ↗ |
| 68 | 2015 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | 4.02M | — | 7.4K | 4.12M | 97.40% | ↗ |
| 69 | 2015 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of R&D | 440.0K | — | 341.7K | 1.38M | 255.2K | 7.4K | 2.42M | 71.02% | ↗ |
| 70 | 2015 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 420.0K | — | 253.8K | 693.3K | 243.6K | 7.4K | 1.62M | 58.53% | ↗ |
| 71 | 2015 | Halley E. Gilbert Senior Vice President, Chief Legal Officer and Secretary | 410.0K | — | 499.1K | 408.9K | 225.5K | 7.4K | 1.55M | 58.54% | ↗ |
| 72 | 2015 | Halley E. Gilbert Senior Vice President, Chief Legal Officer, and Secretary | 410.0K | — | 499.1K | 408.9K | 225.5K | 7.4K | 1.55M | 58.54% | ↗ |
| 73 | 2015 | Tom Graney Chief Financial Officer and Senior Vice President, Finance and Corporate Strategy | 420.0K | — | 89.0K | 242.5K | 231.0K | 113.9K | 1.10M | 30.24% | ↗ |
| 74 | 2014 | Michael J. Higgins Former Senior Vice President, Chief Operating Officer and Chief Financial Officer | 371.8K | — | — | 973.1K | — | 2.56M | 3.91M | 24.89% | ↗ |
| 75 | 2014 | Tom Graney Chief Financial Officer and Senior Vice President, Finance and Corporate Strategy | 131.3K | 200.0K | — | 1.90M | 37.4K | 43.7K | 2.31M | 82.13% | ↗ |
| 76 | 2014 | Tom Graney* Chief Financial Officer and Senior Vice President, Finance and Corporate Strategy | 131.3K | 200.0K | — | 1.90M | 37.4K | 43.7K | 2.31M | 82.13% | ↗ |
| 77 | 2014 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | 2.14M | — | 7.4K | 2.25M | 95.23% | ↗ |
| 78 | 2014 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | 2.14M | — | 7.4K | 2.25M | 95.23% | ↗ |
| 79 | 2014 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of RD | 388.1K | — | — | 560.9K | 159.3K | 7.4K | 1.12M | 50.27% | ↗ |
| 80 | 2014 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of R&D | 388.1K | — | — | 560.9K | 159.3K | 7.4K | 1.12M | 50.27% | ↗ |
| 81 | 2014 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 377.6K | — | — | 527.9K | 133.8K | 7.4K | 1.05M | 50.44% | ↗ |
| 82 | 2014 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 377.6K | — | — | 527.9K | 133.8K | 7.4K | 1.05M | 50.44% | ↗ |
| 83 | 2014 | Halley E. Gilbert Senior Vice President, Chief Legal Officer, and Secretary | 371.0K | — | — | 428.9K | 131.6K | 7.4K | 939.0K | 45.68% | ↗ |
| 84 | 2014 | Halley E. Gilbert* Senior Vice President, Chief Legal Officer, and Secretary | 371.0K | — | — | 428.9K | 131.6K | 7.4K | 939.0K | 45.68% | ↗ |
| 85 | 2014 | Halley E. Gilbert Senior Vice President, Chief Legal Officer and Secretary | 371.0K | — | — | 428.9K | 131.6K | 7.4K | 939.0K | 45.68% | ↗ |
| 86 | 2013 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | 2.30M | — | 7.4K | 2.41M | 95.54% | ↗ |
| 87 | 2013 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | 2.30M | — | 7.4K | 2.41M | 95.54% | ↗ |
| 88 | 2013 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of RD | 376.7K | — | — | 1.23M | 90.4K | 7.4K | 1.70M | 72.13% | ↗ |
| 89 | 2013 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of R&D | 376.7K | — | — | 1.23M | 90.4K | 7.4K | 1.70M | 72.13% | ↗ |
| 90 | 2013 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 366.6K | — | — | 675.5K | 81.8K | 7.4K | 1.13M | 59.71% | ↗ |
| 91 | 2013 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 366.6K | — | — | 675.5K | 81.8K | 7.4K | 1.13M | 59.71% | ↗ |
| 92 | 2013 | Michael J. Higgins Senior Vice President, Chief Operating Officer and Chief Financial Officer | 360.9K | — | — | 552.6K | 86.6K | 7.4K | 1.01M | 54.85% | ↗ |
| 93 | 2013 | Michael J. Higgins Former Senior Vice President, Chief Operating Officer and Chief Financial Officer | 360.9K | — | — | 552.6K | 86.6K | 7.4K | 1.01M | 54.85% | ↗ |
| 94 | 2013 | Tom Graney* Chief Financial Officer and Senior Vice President, Finance and Corporate Strategy | — | — | — | — | — | — | — | — | ↗ |
| 95 | 2013 | Halley E. Gilbert* Senior Vice President, Chief Legal Officer, and Secretary | — | — | — | — | — | — | — | — | ↗ |
| 96 | 2012 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | — | — | 7.4K | 2.32M | 0.00% | ↗ |
| 97 | 2012 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of RD | 365.4K | — | — | 809.8K | 104.1K | 7.4K | 1.29M | 62.93% | ↗ |
| 98 | 2012 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 354.5K | — | — | 699.4K | 111.7K | 7.4K | 1.17M | 59.62% | ↗ |
| 99 | 2012 | Michael J. Higgins Senior Vice President, Chief Operating Officer and Chief Financial Officer | 350.0K | — | — | 625.8K | 99.8K | 7.4K | 1.08M | 57.78% | ↗ |
| 100 | 2012 | Michael J. Higgins Former Senior Vice President, Chief Operating Officer and Chief Financial Officer | 350.0K | — | — | 625.8K | 99.8K | 7.4K | 1.08M | 57.78% | ↗ |
| 101 | 2012 | Tom Graney* Chief Financial Officer and Senior Vice President, Finance and Corporate Strategy | — | — | — | — | — | — | — | — | ↗ |
| 102 | 2012 | Halley E. Gilbert* Senior Vice President, Chief Legal Officer, and Secretary | — | — | — | — | — | — | — | — | ↗ |
| 103 | 2011 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | — | — | 4.4K | 1.12M | 0.00% | ↗ |
| 104 | 2011 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of RD | 350.0K | — | — | 637.9K | 57.4K | 4.4K | 1.05M | 60.76% | ↗ |
| 105 | 2011 | Mark G. Currie, Ph.D. Senior Vice President, RD and Chief Scientific Officer | 350.0K | — | — | 637.9K | 57.4K | 4.4K | 1.05M | 60.76% | ↗ |
| 106 | 2011 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 339.6K | — | — | 550.9K | 55.7K | 4.4K | 950.6K | 57.95% | ↗ |
| 107 | 2011 | Michael J. Higgins Senior Vice President, Chief Operating Officer and Chief Financial Officer | 325.0K | — | — | 405.9K | 42.7K | 4.4K | 778.0K | 52.17% | ↗ |
| 108 | 2010 | Mark G. Currie, Ph.D. Senior Vice President, Chief Scientific Officer and President of RD | 335.0K | — | — | 591.2K | 53.4K | 4.4K | 984.0K | 60.08% | ↗ |
| 109 | 2010 | Mark G. Currie, Ph.D. Senior Vice President, RD and Chief Scientific Officer | 335.0K | — | — | 591.2K | 53.4K | 4.4K | 984.0K | 60.08% | ↗ |
| 110 | 2010 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | 821.1K | — | 4.4K | 925.5K | 88.72% | ↗ |
| 111 | 2010 | Michael J. Higgins Senior Vice President, Chief Operating Officer and Chief Financial Officer | 280.0K | — | — | 558.3K | 22.3K | 4.4K | 865.1K | 64.54% | ↗ |
| 112 | 2010 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 325.0K | — | — | 131.4K | 51.8K | 236.7K | 744.8K | 17.64% | ↗ |
| 113 | 2009 | Thomas A. McCourt Senior Vice President, Marketing and Sales and Chief Commercial Officer | 102.3K | — | — | 1.22M | — | 2.0K | 1.32M | 92.10% | ↗ |
| 114 | 2009 | Mark G. Currie, Ph.D. Senior Vice President, RD and Chief Scientific Officer | 315.0K | 8.0K | — | 651.8K | — | 4.4K | 979.2K | 66.56% | ↗ |
| 115 | 2009 | Michael J. Higgins Senior Vice President, Chief Operating Officer and Chief Financial Officer | 265.0K | 5.0K | — | 415.6K | — | 4.4K | 690.0K | 60.23% | ↗ |
| 116 | 2009 | Peter M. Hecht, Ph.D. Chief Executive Officer | 100.0K | — | — | — | — | 4.4K | 564.3K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas A. McCourt | Chief Executive Officer & Director | 2M | male |
| Michael Shetzline | Chief Medical Officer, Senior Vice President and Head of Research & Drug Development | 756.7K | — |
| John Minardo | Senior Vice President, Chief Legal Officer & Secretary | 717.5K | male |
| Rosario Lobrutto | Vice President & Global Head of Technical Operations | — | — |
| Tammi Gaskins | Senior Vice President & Chief Commercial Officer. | — | female |
| Ronald Silver | Senior Vice President, Corporate Controller & Principal Accounting Officer | — | male |
| Jeff Ruberti | Chief Strategy Officer | — | male |
| Greg Martini | Senior Vice President, Chief Financial Officer & Investor Relations | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IRWD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
